Corporate Profile

At Talis, we strive to deliver excellence in point of care diagnostics by increasing access to timely and accurate testing that can help combat the spread of known and emerging infectious diseases.

Stock Information

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Press Releases

30 Aug '21
Talis Biomedical Announces CEO Transition
Kim Popovits to serve as interim CEO MENLO PARK, Calif., Aug. 30, 2021 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a company dedicated to developing innovative molecular diagnostic tests for infectious diseases at the point-of-care, today announced that effective immediately

View More

Recent Events

View More

Executive Team

Kim Popovits

Kim Popovits

Interim Chief Executive Officer

Roger Moody, M.B.A.

Roger Moody

Chief Financial Officer

Douglas Liu

Douglas Liu

Chief Operating Officer

Rob Kelley

Rob Kelley

Chief Commercial Officer

View More